ADV7103

Small molecule

AAdvicenne Pharma

ADV7103 is one of 5 small molecule programs targeting Cystinuria. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CystinuriaActive, not recruiting

CystinuriaPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

4 competitors in Cystinuria

#DrugCompanyPhaseTrials

Farxiga

Thiola Ec

2 3

Bucillamine

RRevive Therapeutics, Ltd.

Phase 2

1 4

Samsca

ADV7103

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Cystinuria2 trials

Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children

Withdrawn·AAdvicenne Pharma·Phase 2/3·NCT04147871

Study Evaluating Patients With Cystinuria

Withdrawn·AAdvicenne Pharma·Phase 2/3·NCT04137978

Fasting Conditions1 trial

A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

Completed·AAdvicenne Pharma·Phase 1·NCT07446881·12 enrolled

Unspecified2 trials

Study Evaluating Subjects With Distal Renal Tubular Acidosis

Terminated·AAdvicenne Pharma·Phase 3·NCT03644706·3 enrolled

Extension Study in Primary Distal Renal Tubular Acidosis

Withdrawn·AAdvicenne Pharma·Phase 3·NCT03831152

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for ADV7103. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ADV7103 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ADV7103. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Advicenne Pharma company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: AAdvicenne Pharma

ADV7103

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Cystinuria2 trials

Fasting Conditions1 trial

Unspecified2 trials

References

Drug Info

Quick Facts

Related News